SHANGHAI: China's new medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on patients, state news agency Xinhua said on Saturday. The State Medical Insurance Administration said ...
- Commentary: The hidden dividends of a longer life
- WOULD YOU BUY THESE 52-WEEK LOWS LARGE-CAP BLUE-CHIP SINGAPORE STOCKS NOW?
- WOTC – Education policy
- WOTC – Is HDB flat a good investment?
- Creative Capital: The American socialite championing Singapore talent and women’s rights
- WOTC – Use of town council software
- WOTC – Dispute over Oxfam report